About
Fabtech Technologies Limited operates as a biopharma engineering company that provides aseptic manufacturing facilities internationally. The company offers designing, engineering, procurement, installation, and testing of pharmaceutical equipment. It serves pharmaceuticals, biotech, and healthcare companies. The company was founded in 2001 and is based in Mumbai, India.
Key Metrics
as of Sep 2026Market Cap668 Cr
P/E13.70
Div Yield0.40 %
Book ValueβΉ94.40
52w HighβΉ263.00
52w LowβΉ126.00
Face ValueβΉ10.00
Quarterly Results
Rs. Crores Β· hover row for definition| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Sales | 49.15 | 110.20 | 47.16 | 80.57 | 30.13 | 97.36 | 64.27 | 49.73 |
| Expenses | 49.40 | 101.54 | 52.00 | 57.73 | 39.06 | 82.72 | 57.12 | 41.42 |
| Operating Profit | -0.25 | 8.66 | -4.84 | 22.84 | -8.93 | 14.64 | 7.15 | 8.31 |
| OPM % | -0.51 | 7.86 | -10.26 | 28.35 | -29.64 | 15.04 | 11.12 | 16.71 |
| Other Income | 3.72 | 10.15 | 7.67 | 3.78 | 2.40 | 3.58 | 2.39 | 1.95 |
| Depreciation | 1.19 | 1.17 | 1.22 | 1.23 | 1.32 | 0.52 | 0.56 | 0.57 |
| Interest | 0.86 | 0.98 | 0.91 | 1.13 | 1.34 | 1.06 | 0.39 | 0.22 |
| Profit before tax | 1.42 | 16.66 | 0.70 | 24.26 | -9.19 | 16.64 | 8.59 | 9.47 |
| Tax % | 25.35 | 36.67 | -114.29 | 11.91 | -0.22 | 28.00 | 29.57 | 12.04 |
| Net Profit | 1.06 | 10.55 | 1.49 | 21.38 | -9.16 | 11.98 | 6.05 | 8.33 |
| EPS in Rs | 0.24 | 2.37 | 0.34 | 6.60 | -2.83 | 3.70 | 1.87 | 2.57 |
Profit & Loss
Annual Β· Rs. Crores| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|
| Sales | 268.00 | 236.00 | 225.00 | 194.00 | 257.00 | 121.00 | 133.00 |
| Expenses | 250.00 | 210.00 | 190.00 | 169.00 | 225.00 | 110.00 | 119.00 |
| Operating Profit | 18.00 | 27.00 | 35.00 | 25.00 | 32.00 | 11.00 | 14.00 |
| OPM % | 7.00 | 11.00 | 16.00 | 13.00 | 13.00 | 9.00 | 11.00 |
| Other Income | 24.00 | 30.00 | 4.00 | 6.00 | 2.00 | 2.00 | 5.00 |
| Interest | 4.00 | 3.00 | 3.00 | 5.00 | 3.00 | 2.00 | 2.00 |
| Depreciation | 5.00 | 2.00 | 2.00 | 2.00 | 1.00 | 0.00 | 0.00 |
| Profit before tax | 32.00 | 52.00 | 35.00 | 24.00 | 31.00 | 11.00 | 16.00 |
| Tax % | 25.00 | 26.00 | 25.00 | 27.00 | 27.00 | 29.00 | 27.00 |
| Net Profit | 24.00 | 38.00 | 26.00 | 18.00 | 23.00 | 8.00 | 12.00 |
| EPS in Rs | 5.46 | 11.85 | 89.04 | 63.46 | 81.23 | 7,630.00 | 11,720.00 |
| Dividend Payout % | 11.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Balance Sheet
Annual Β· Rs. Crores β latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|
| Equity Capital | 44.00 | 32.00 | 3.00 | 3.00 | 3.00 | 0.01 | 0.01 |
| Reserves | 345.00 | 125.00 | 121.00 | 79.00 | 64.00 | 44.00 | 37.00 |
| Borrowings | 46.00 | 62.00 | 11.00 | 34.00 | 19.00 | 9.00 | 1.00 |
| Other Liabilities | 122.00 | 120.00 | 113.00 | 91.00 | 83.00 | 70.00 | 84.00 |
| Total Liabilities | 558.00 | 340.00 | 248.00 | 207.00 | 169.00 | 124.00 | 122.00 |
| Fixed Assets | 52.00 | 55.00 | 5.00 | 4.00 | 3.00 | 2.00 | 2.00 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 24.00 | 28.00 | 36.00 | 14.00 | 14.00 | 5.00 | 11.00 |
| Other Assets | 481.00 | 258.00 | 207.00 | 190.00 | 152.00 | 116.00 | 109.00 |
| Total Assets | 558.00 | 340.00 | 248.00 | 207.00 | 169.00 | 124.00 | 122.00 |
Cash Flows
Annual Β· Rs. Crores β latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | -1.00 | -53.00 | 60.00 | -16.00 | -5.00 | -9.00 | 27.00 |
| Cash from Investing Activity | -117.00 | 12.00 | -28.00 | 2.00 | -9.00 | 4.00 | -20.00 |
| Cash from Financing Activity | 187.00 | 16.00 | -14.00 | 12.00 | 10.00 | 6.00 | 5.00 |
| Net Cash Flow | 69.00 | -24.00 | 18.00 | -2.00 | -4.00 | 1.00 | 13.00 |
| Free Cash Flow | -4.00 | -76.00 | 59.00 | -16.00 | -6.00 | -3.00 | 21.00 |
| CFO/OP % | 58.00 | -161.00 | 191.00 | -24.00 | -3.00 | -61.00 | 222.00 |
Ratios
Annual Β· Days / % β latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 196.00 | 190.00 | 153.00 | 187.00 | 123.00 | 135.00 | 110.00 |
| Inventory Days | 45.00 | 45.00 | 49.00 | 69.00 | 17.00 | 39.00 | 22.00 |
| Days Payable | 164.00 | 208.00 | 173.00 | 215.00 | 136.00 | 150.00 | 82.00 |
| Cash Conversion Cycle | 77.00 | 27.00 | 29.00 | 41.00 | 5.00 | 25.00 | 51.00 |
| Working Capital Days | 119.00 | 61.00 | 47.00 | 65.00 | 37.00 | 15.00 | -19.00 |
| ROCE % | 11.00 | 20.00 | 30.00 | 29.00 | 49.00 | 27.00 | β |
Corporate Actions
1 records| Action | Ex Date | Record Date | Ratio | Amount (βΉ) | Notes |
|---|---|---|---|---|---|
| Dividend | 17 Aug 2026 | 17 Aug 2026 | β | 0.60 |
Announcements
5 filingsShareholding Pattern
Open on BSEFinancial Results β Filings
Open on BSEBoard Filings
Open on BSEAnnual Reports
Credit Ratings
-
Rating update15 Oct 2025 from crisil
-
Rating update11 Sep 2025 from crisil
-
Rating update12 Aug 2025 from crisil